Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
554 studies found for:    "Lupus"
Show Display Options
RSS Create an RSS feed from your search for:
"Lupus"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated A Research Study to Assess if CC-930 is Safe in Treating Subjects With Discoid Lupus Erythematosus
Condition: Discoid Lupus
Interventions: Drug: CC-930;   Drug: Placebo
2 Completed Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE)
Condition: Lupus
Interventions: Biological: MEDI-545;   Biological: MEDI 545
3 Completed Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients
Condition: Lupus Nephritis
Intervention:
4 Recruiting Duke Lupus Registry
Conditions: Systemic Lupus Erythematosus;   Cutaneous Lupus
Intervention:
5 Completed Lupus Genetics Studies
Condition: Systemic Lupus Erythematosus
Intervention:
6 Withdrawn Open Label Pilot Trial of Rituximab in Lupus Membranous Nephritis
Condition: Lupus Nephritis
Intervention: Drug: Rituximab
7 Active, not recruiting Lupus Flares and Histological Renal Activity at the End of the Treatment (LuFla)
Condition: Lupus Nephritis
Intervention: Procedure: Renal Biopsy
8 Withdrawn Steroids in the Maintenance of Remission of Proliferative Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: prednisolone;   Drug: Placebo
9 Terminated Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
Conditions: Cutaneous Lupus;   Lupus
Interventions: Drug: AMG 557;   Drug: AMG 557 Placebo
10 Completed Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions
Condition: Discoid Lupus Erythematosus
Interventions: Drug: ASF 1096 0.5 % cream applied twice daily;   Drug: Cream vehicle for ASF 1096 cream applied twice daily
11 Completed Assess the Efficacy and Safety of Multi-target Therapy in Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Tacrolimus+Mycophenolate mofetil;   Drug: Cyclophosphamide
12 Recruiting Study to Determine if Gardasil Vaccine is Safe and Effective in Lupus Patients
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Gardasil
13 Unknown  Effect of Mesenchymal Stem Cell Transplantation for Lupus Nephritis
Condition: Lupus Nephritis
Intervention: Biological: mesenchymal stem cell
14 Recruiting RING - Rituximab for Lupus Nephritis With Remission as a Goal
Condition: Lupus Nephritis
Interventions: Drug: RTX infusions;   Other: Standard of Care
15 Unknown  Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Human Umbilical Cord derived MSCs;   Drug: Cyclophosphamide
16 Recruiting Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Brentuximab vedotin;   Drug: Placebo
17 Recruiting Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Anifrolumab;   Drug: Placebo
18 Completed Long-Acting Tacrolimus for the Treatment of Resistant Lupus Nephritis
Condition: Lupus Nephritis
Intervention: Drug: Long-acting tacrolimus (Advagraf, Astellas Pharma)
19 Completed A Study to Evaluate the Efficacy and Safety of CEP-33457 in Patients With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Lupuzor;   Drug: Placebo
20 Completed
Has Results
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
Conditions: Lupus Erythematosus, Discoid;   Lupus Erythematosus, Systemic
Interventions: Drug: R932333;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.